Finzati - Logo
SLRX logo

Salarius Pharmaceuticals, Inc.

SLRX • Biotechnology
$0.84
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$446,853.12
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 2.13Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Mar 31, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.84
Change0.00%
Shares Out531.97K
Market Cap$446.85K
Enterprise Value$-7.84M
52W Range0.52 - 52.95
Beta0.32
P/E-0.03
P/B0.10
P/FCF-0.05
EV/EBITDA0.53
EV/FCF0.94

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 2.13Weak profitability

Analyst view

Analyst sentiment and price target

SLRX
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0

Company Overview

IPO: 1/29/2015
Industry: Biotechnology
P/B i: 0.10
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 2.13
Quick Ratio: 2.13
Status: Good

Insider Transactions

Recent executive and insider activity

HANISH ARNOLD C
Transaction: 08/21/2020
BUY
Change
+4,000
Price
$0.98
Filing
08/24/2020
Type
BUY
HANISH ARNOLD C
Transaction: 02/11/2020
BUY
Change
+4,350
Price
$1.15
Filing
02/12/2020
Type
BUY